CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
67 hedge funds and large institutions have $178M invested in Concert Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 68 → 67 (-1)
Holders
67
Holding in Top 10
2
Calls
$152K
Puts
–
Top Buyers
| 1 | +$17.6M | |
| 2 | +$6.57M | |
| 3 | +$6.54M | |
| 4 |
Millennium Management
New York
|
+$2.87M |
| 5 |
Bank of New York Mellon
New York
|
+$1.81M |
Top Sellers
| 1 | -$5.34M | |
| 2 | -$3.94M | |
| 3 | -$2.23M | |
| 4 |
Jennison Associates
New York
|
-$2.17M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.52M |